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tivity during a cognitive task using functional magnetic resonance imaging (fMRI). Sixteen fibromyalgia patients
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working memory performance using a modified N-back working memory task while undergoing Blood Oxygen
Level Dependent (BOLD) fMRImeasurements. Fibromyalgia patients and controls did not differ inworkingmemory
performance. Subjective appraisal of cognitive function was associated with better performance (accuracy) on the
working memory task in healthy controls but not in fibromyalgia patients. In fibromyalgia patients, increased per-
ceived cognitive difficulty was positively correlatedwith the severity of their symptoms. BOLD response during the
working memory task did not differ between the groups. BOLD response correlated with task accuracy in control
subjects but not in fibromyalgia patients. Increased subjective cognitive impairment correlated with decreased
BOLD response in both groups but in different anatomic regions. In conclusion, “fibrofog” appears to be better
characterized by subjective rather than objective impairment. Neurologic correlates of this subjective experience
of impairment might be separate from those involved in the performance of cognitive tasks.
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Perceived cognitive dysfunction (“fibrofog”) is an increasingly
appreciated clinical complaint in fibromyalgia. Along with painful
symptoms, over 50% of fibromyalgia patients experience distressing
subjective cognitive impairment (Katz et al., 2004; Yunus et al., 1981).
The most common complaints encompass the abilities to attend,
concentrate, remember, use language, multi-task, and organize infor-
mation. Dyscognition contributes significantly to both functional and
work disability in fibromyalgia. Commensurate with its increasing
recognition, its subjective evaluation has been incorporated into the
2010 preliminary American College of Rheumatology fibromyalgia
diagnostic criteria (Wolfe et al., 2010).
Persons with fibromyalgia commonly perceive discordance between
how they feel about their abilities and how they actually perform. In0/5-2531, Bethesda, MD 20892,
ss article under the CC BY-NC-ND liceone seminal study, patients with rheumatoid arthritis, ankylosing spon-
dylitis, and fibromyalgiawere asked to rate their ability to perform sever-
al physical activities andwere then videotaped actually performing these
activities (Hidding et al., 1994). A striking discordance between self-
reported ability and observed functional disability was observed in
fibromyalgia thatwas not found in other patientswith rheumatic disease.
It is possible that the dyscognition of fibromyalgia may reflect a similar
phenomenon, with discordance between the subjective experience of
performing cognitive tasks and objective performance on those tasks.
To date, the entire body of science on dyscognition in fibromyalgia
includes ~20 publications, mostly small population comparisons of
fibromyalgia patients to controls performing cognitive tests (Ambrose
et al., 2012). In summary, objective differences of small effect sizes
have been demonstrated in performance on some neuropsychological
tests of attention, executive function, and memory (Glass and Park,
2001). However, these findings often required experimental provoca-
tion (i.e. distraction, stress) to demonstrate effects (Dick et al., 2002;
Glass, 2009; Glass et al., 2011; Leavitt and Katz, 2006; Leavitt and Katz,
2009; Reyes Del Paso et al., 2012; Seo et al., 2012) and effects arense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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et al.; Walitt et al., 2008).
Only a few studies have investigated the neurocognitive correlates of
cognitive impairment infibromyalgia. Using fMRI and a simple response
inhibition task selected to ensure comparable performance (Go/No-Go
task), Glass, et al. found that, compared to controls, fibromyalgia
patients had less activation in several task-related brain areas and
increased activation elsewhere in the brain (Glass et al., 2011). Using
the 2back working memory task paradigm, Seo, et al. also found that
fibromyalgia patients had less activation in brain areas related to
working memory together with a small clinical difference in
performance (88.26% vs. 95.56% accuracy) (Seo et al., 2012). More
recently, Čeko, et al. reported finding no difference in performance or
BOLD response between 28 fibromyalgia patients and 23 healthy
controls on multiple levels of the N-back task (Čeko et al., 2015). All
studies usedmethods that contrasted two different task difficulty levels
(NoGo N Go; Nback N 0back). These papers present a variety of interpre-
tations; 1) that decreases in task-related brain activity represent a deficit
in task ability, perhaps due to overlapping networks leading to reduced
resources to perform task) (Glass et al., 2011), 2) that impairment of
the prefrontal cortex may lead to inappropriate organization of informa-
tion (Seo et al., 2012), and 3) that there is no evidence of a measureable
difference in Nback cognitive performance or compensatory neural re-
cruitment in task-related brain networks (Čeko et al., 2015). All three
studies adjusted for patient characteristics in their analyses but did not
consider the discordance between the severity of subjective cognitive
complaint and (objective) task performance.
Clinically, the objective consequences of dyscognition in fibromyal-
gia are not clear (Shmygalev et al., 2014). Cognitive deficits are not
overtly obvious to medical observation, certainly far less than what is
seen in pathologically-defined neuropsychiatric dementias such as
Alzheimer's disease and vascular dementia. Objective differences
noted on cognitive testing also correlate poorly with self-perception of
cognitive deficits (Tesio et al., 2015). The dyscognition of fibromyalgia
is perhaps better defined by the distressing intrusiveness of subjective
cognitive symptoms rather than by a clinically-relevant cognitive
deficit.
Here, we aimed to separate brain mechanisms related to subjective
appraisal (subjective dyscognition) from those related to performance
on a cognitive workingmemory task (objective dyscognition).We eval-
uated subjective cognitive function, as well as objective cognitive task
performance, and brain activity during a cognitive task using BOLD
functional magnetic resonance imaging (fMRI).
2. Materials and method
2.1. Subjects
Eighteen right-handed, female fibromyalgia patients and a group of
16 age-matched female right-handed healthy controls participated in
this study. One fibromyalgia patient was excluded from the study
because shewas found to be pregnant during screening. One fibromyal-
gia patient and three healthy controls were unable to demonstrate
understanding of the N-back task during the practice sessions and
were excluded from analyses. All fibromyalgia patients (n = 16) met
the 1990 American College of Rheumatology fibromyalgia criteria and
did not have concomitant medical diagnoses. Healthy controls (n =
13) did not have any medical or psychiatric diagnoses, were not taking
any medications, and did not meet fibromyalgia diagnostic criteria.
Exclusion criteria for fMRI participation included left-handedness,
pregnancy, cardiac pacemakers or other bodymetals, and claustrophobia.
Behavioral data are missing on one patient for N-back task and one con-
trol for the N-back task and Multiple Ability Self-Report Questionnaire
(MASQ).
This studywas approved by theMedStar Health Institutional Review
Board (protocol number 2010–050).2.2. Measures of fibromyalgia impact and symptoms
Fibromyalgia Impact Questionnaire (FIQ) is a validated question-
naire designed to assess the spectrum of problems related to fibromyal-
gia and treatment responses (Burckhardt et al., 1991). It evaluates three
domains: function, overall impact, and polysymptom burden related to
pain, fatigue, sleep, and mood issues. The original FIQ is scored on a
0–100 scale with high scores indicating more severe symptoms. A 14%
change in FIQ scores is considered the minimally clinical important
difference (MCID) in fibromyalgia symptoms (Bennett, 2005). Patients
enrolled in fibromyalgia clinical trials typically have FIQ scores of 50 or
greater (Bennett, 2005; Hauser et al., 2013; Williams and Arnold,
2011). As FIQ scores represent the full spectrum of fibromyalgia com-
plaints, FIQ scorewas used as a representative score of symptomburden
in our imaging analyses.
Brief Pain Inventory (BPI) is a validated measurement of pain sever-
ity and pain interference (Tan et al., 2004). Both are scored on a 0–10
scales, with high scores indicating more severe pain. Patients enrolled
in fibromyalgia clinical trials typically have BPI scores of about 6
(Hauser et al., 2013). A 2-3 point change is typically considered the
MCID in pain (Keller et al., 2004; Williams and Arnold, 2011).
Multidimensional Fatigue Inventory (MFI) is a validated measure of
fatigue severity that provides subscales of general fatigue, physical
fatigue, reduced activity, reduced motivation and mental fatigue
(Smets et al., 1995). The MFI is scored on a 4–20 scale with high scores
indicating more severe symptoms. There is no proposed MCID cut-off
with the MFI. Patients enrolled in fibromyalgia clinical trials typically
have MFI scores of approximately 14 (Hauser et al., 2013). In this
study, scores are reported in terms of “general fatigue” and “mental
fatigue” (Smets et al., 1995; Williams and Arnold, 2011). The MFI
questions to determine mental fatigue are currently used in other
tools to assess “fibrofog” (Boomershine, 2010).
2.3. Measures of subjective and objective dyscognition
Subjective dyscognition (subjective cognitive appraisal) was mea-
sured using the Multiple Ability Self-Report Questionnaire (MASQ),
which assesses the subjective appraisal of cognitive difficulties in five
cognitive domains: language, visual-perceptual ability, verbal memory,
visual–spatial memory, and attention/concentration. The MASQ sub-
scales are scored on an 8–40 scale with high scores indicating greater
perceived difficulties. There is no proposed MCID cut-off with the
MASQ. Patients enrolled in a fibromyalgia research clinic typically
have MASQ subscales scores of approximately 20. In this study, sub-
scale scores are reported in terms of “Verbal Memory”, “Language”,
and “Attention/Concentration” (Seidenberg et al., 1994; Williams
and Arnold, 2011) as these three domains are most highly related
to the cognitive task during fMRI imaging (see below). The correla-
tion coefficients for Verbal Memory, Language, and Attention/Con-
centration with 2back accuracy in healthy controls were −0.68,
−0.59, and −0.2, respectively. For this reason, Verbal Memory is
used as a representative score of subjective cognitive appraisal in
our imaging analyses.
2.4. Cognitive task during fMRI
Objective dyscognition was measured using a modified version of
the N-backworkingmemory task while undergoing fMRI. Themodified
N-back task used in this study has an increased overall cognitive de-
mand compared to the classic N-back task. This taskwas employed pre-
viously by our group in other patient populations (Rayhan et al., 2013).
Briefly, blocks of 9 pseudo-randomized uppercase letters (A, B, C, and
D) were displayed for 1000 ms followed by 1500 ms of blank screen.
Subjects responded using a four button box. In the 0back condition,
subjects were asked to press the button that corresponds to the letter
currently displayed on the screen. In the 2back condition, subjects
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presented two letters previously. This requires participants to simulta-
neously recall the letter shown two trials previously to the current
displayed letter, push the button that corresponds to that previously
shown letter, and keep track of the current sequence of presented
letters to inform future answers. In the classic N-back task (Jaeggi
et al., 2010) only a proportion of the displayed letters are “targets”
(typically 30%); here subjects are required to continuously specify the
current letter (0back) or the letter presented two previously (2back).
Thus every letter is a “target” making this modified version of the
N-back more attention-demanding than the classic N-back task.
Alternating blocks of 0back and 2back taskswere presented for 5 cy-
cles. Immediately before each block, an instruction screen was present-
ed to prepare the participant for each task. Between 0back and 2back
blocks participants had a 8000 ms “rest” period in which a cross-hair
was visually presented and there was no task. No feedback on perfor-
mance was given. Stimuli were presented using the E-prime software
(Psychology Software Tools, Pittsburgh, PA).
Accuracy was measured by subtracting the sum of misses and false
positives from the number of condition items then dividing by the
number of condition items. Reaction time was expressed in seconds.
Prior to entering the scanner, subjects were familiarized with the
N-back paradigm through practice sessions on a standalone computer.
Each participant was given 15 min to practice both tasks on a day
prior to scanning and allowed to practice each task once on the day of
scanning. This ensured that the subjects understood the directions and
expectations during the sessions.
2.5. fMRI acquisition
All brain images were collected on a Siemens 3 T Tim Trio scanner
equipped with a standard 12-channel head coil array. fMRI data were
acquired using a T2⁎-weighted gradient-echo planar imaging (EPI) dur-
ing the N-back task. The following acquisition parameters were used:
repetition time (TR) 2500 ms, echo time (TE) 30 ms, 90 degrees flip
angle, 205 ∗ x205-mm2 field of view (FOV) 64 × 64matrix, and 47 slices
(resolution 3.2 × 3.2 × 3.2 mm).
2.6. fMRI preprocessing
One patient did not complete the fMRI part of the study, and task
performance data are missing for one healthy control. The imaging
data were preprocessed and analyzed using SPM5 (Welcome
Department of Imaging Neuroscience, London, UK; online at http:/
www.fil.ion.ucl.ac.uk) in MATLAB (The Math Works Inc., Natick, MA).Table 1
Sample characteristics.
Characteristics Patients (n = 16) mean (SD
Age 44.9 (±10.2)
Pain:
BPI severity (scale range: 0–10) 4.59 (±2.26)
BPI interference (0–10) 4.42 (±2.84)
FIQ impact (0–100) 53.5 (±12.8)
Fatigue:
MFI general fatigue (4–20) 17.3 (±2.53)
MFI mental fatigue (4–20) 14.3 (±4.16)
Subjective cognitive appraisal:
MASQ verbal memory (8–40) 21.7 (±7.55)
MASQ attention/concentration (8–40) 21.8 (±5.70)
MASQ language (8–30) 18.6 (±5.72)
N-back accuracy (%) (n = 15)
0-back 94.8 (±7.12)
2-back 51.8 (±23.6)
N-back reaction time (ms) (n = 15)
0-back 719 (±169)
2-back 690 (±310)
BPI, Brief Pain Inventory; FIQ, Fibromyalgia Impact Score; MFI, Multidimensional Fatigue InvenPreprocessing steps included spatial realignment to the first fMRI
volume and six-parameter (three translations and three rotations)
rigid-body correction for head motion, co-registration to the
high-resolution (1.0 mm3) T1-weighted MPRAGE anatomical image,
segmentation to identify voxels corresponding to gray matter, white
matter, and cerebrospinal fluid, followed bywarping to the correspond-
ing tissue templates from SPM, spatial normalization into MNI space,
and spatial smoothing using a Gaussian kernel of 8 mm. MPRAGE pa-
rameters were: TR/TE/TI = 1900/2.52/900 ms, flip angle = 90,176,
1.00 mm thick slices, FOV = 250 × 250 mm2; matrix = 246 × 256,
and resolution = 1.02 × 0.98 × 1.00 mm3. To ensure that there were
no significant group differences in head motion that might affect the
fMRI analysis, mean total head motion (defined as the square root of
the sum of squares of the six motion parameters) was compared
between controls (0.08 ± 0.04) and patients (0.11 ± 0.07; p = 0.13)
or between any of the individual six motion parameters (translations:
x-direction p = 0.15, y-direction p = 0.81, z-direction p = 0.73;
rotations: pitch p = 0.12, roll p = 0.81, yaw p = 0.24).
2.7. Statistical analysis of behavioral data
Data are presented as means ± SD. Statistical analysis of subjective
data (pain, FIQ, BPI, MASQ, fatigue) was performed using independent
sample t-tests in SPSS version 21. Pearson correlation analyses were
used to determine the association between N-back accuracy on the
2back task and subjective scores. Correlational analyses were not possi-
ble with 0back accuracy scores, since participants in both groups had
near perfect performance at this N-back level.
2.8. Statistical analysis of fMRI data
The preprocessed fMRI data were entered into a first–level individu-
al analysis that compared the BOLD response during the 2back taskwith
the 0back task (2back N 0back contrast). Additionally, contrasts for both
conditions compared to the implicit baseline were computed. For these
analyses, the time courses of the six motion parameters were included
as regressors of no interest.
The contrast images were then entered into a second-level analysis
to evaluate group differences in BOLD response during task perfor-
mance (2back N 0back) across the whole brain. Group differences
were also examined in 0back N baseline and 2back N baseline to account
for possible influence of different baseline fMRI levels to task-related
fMRI activity. Finally, we investigated the relationship between fMRI
activity during task performance on the 2back task and task accuracy,
and between fMRI activity during task performance on the 2back task) Controls (n = 13) mean (SD) p-value
44.2 (±11.2) 0.87
0.71 (±1.10) b0.001
0.26 (±0.61) b0.001
18.8 (±9.65) b0.001
8.38 (±3.20) b0.001
6.19 (±2.36) b0.001
13.1 (±3.12) b0.001
13.1 (±4.26) b0.001
12.1 (±3.08) b0.001
(n = 12)
96.5 (±4.07) 0.65
64.7 (±26.2) 0.19
(n = 12)
670 (±129) 0.39
576 (±252) 0.31
tory; MASQ, Multiple Ability Self-Report Questionnaire.
Fig. 1. Relationship between perceived cognitive difficulty and task performance and
fibromyalgia symptoms. A) Perceived cognitive difficulty (MASQ verbal memory score)
was negatively associated with Nback task performance (2back accuracy) in controls
(n = 12, r =−0.66, p = 0.02), but not in fibromyalgia patients (n = 15, r = 0.18, p =
0.52); controls, black; patients, red. B) In patients, perceived cognitive difficulty (MASQ
verbal memory score) was positively associated with the severity of fibromyalgia (FIQ
score), n = 16, r = 0.65, p = 0.005. (For interpretation of the references to color in this
figure, the reader is referred to the online version of this chapter.)
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ered significant at a voxel-wise threshold of p b 0.01 and cluster-
corrected for multiple comparisons (p b 0.05) using random-field theo-
ry (RFT).
3. Results
3.1. Demographics and clinical data
The characteristics of the fibromyalgia and healthy control groups
are shown in Table 1. There were no significant differences in age
between the groups (p = 0.87). The BPI, total FIQ, and fatigue scores
(general, total) for fibromyalgia subjects were clinically and statistically
different from controls (p b 0.001). All of the above measures were
significantly positively correlated in patients (p b 0.03). To avoid issues
ofmultiple correlations, total FIQ scorewas used as the compoundmea-
sure of fibromyalgia impact and symptoms in further analyses as it is a
comprehensive and accurate measure of fibromyalgia patients' overall
condition. The MASQ scores revealed lower ability in fibromyalgia pa-
tients compared to controls (difference of 8.6 points for verbal memory
and attention/concentration; 6.5 points for language, p b 0.001). The
three subscales of MASQ were highly positively correlated (p b 0.001).
The MASQ Verbal Memory score, which most closely reflects the
processes involved in the fMRI task, was used as the measure of subjec-
tive cognitive appraisal for further analyses. Clinically, these data charac-
terize a fibromyalgia group with substantial pain, functional disability,
and subjective cognitive complaints compared to controls.
There was no significant difference between groups on either 0back
or 2back task accuracy (0back p = 0.65, 2back p = 0.19) or reaction
time (0back p = 0.39, 2back p = 0.31).
3.2. Relationship between cognitive task performance and subjective
cognitive appraisal
In controls, the appraisal of verbal memory faculty as measured by
the MASQ verbal memory score was negatively associated with 2back
accuracy (r =−0.66, p = 0.02; Fig. 1A), with subjects who reported
less cognitive difficulty demonstrating better task performance. Howev-
er, no such association was found for fibromyalgia patients (r = 0.18,
p= 0.52; Fig. 1A). Thus, while controls demonstrated the expected cor-
relation between subjective cognitive appraisal and task performance,
in fibromyalgia patients, subjective cognitive appraisal was not related
to cognitive performance.
3.3. Relationship of task performance and subjective cognitive appraisal
with fibromyalgia impact
In patients, no significant association was found between cognitive
performance (2back accuracy) on the N-back task and fibromyalgia im-
pact (FIQ r = 0.19, p = 0.55). However, the FIQ score in patients was
significantly correlated with subjective cognitive appraisal (MASQ Ver-
bal Memory r=0.65, p=0.005, Fig. 1B; in controls this correlationwas
not significant, r = 0.07, p = 0.82). Thus, patients with greater symp-
toms severity reported greater perceived cognitive difficulties.
3.4. N-back task-related BOLD response
N-back task-related activation (2back N 0back contrast) was ob-
served in fibromyalgia patients and healthy controls in fronto-parietal
brain areas typically associated with working memory (dorsolateral
and ventrolateral prefrontal cortices (DLPFC, VLPFC), superior and infe-
rior parietal lobules (SPL, IPL), supplemental motor area (Bernstein
et al., 2003), anterior cingulate cortex (ACC), insula, precuneus, cerebel-
lum) (p b 0.05 cluster-corrected; Fig. 2, Table 2). There were no signifi-
cant differences between groups in the 2back N 0back contrast.To assess the contribution of baseline activation, which might be al-
tered in the patient population, group differences were also evaluated
betweenfibromyalgia patients and controls for each condition separate-
ly relative to the implicit baseline (2back N baseline, 0back N baseline).
No significant group differences were found.3.5. Nback-related BOLD response and objective task performance
Controls showed a positive association between BOLD response and
task accuracy during the 2back in the right anterior insula/putamen,
right frontal operculum (FrOP), left putamen, left caudate, right
premotor cortex (PMC) and right DLPFC (p b 0.05 cluster-corrected,
Fig. 3A, Table 3). Fibromyalgia patients showed no such association in
any region. Between-group comparison showed significantly stronger
association between 2back accuracy and BOLD response in controls
compared to patients in the right anterior insula (Fig. 3B, Table 3).
Fig. 2. BOLD response for the 2back N 0back contrast in healthy controls and fibromyalgia
patients. Both groups demonstrated increased fMRI activations in 2back N 0back in a
widespread fronto-parietal network of brain regions typically activated in working
memory tasks, including bilateral DLPFC, VLPFC, parietal cortices, precuneus, SMA, ACC,
and insula (p b 0.05 cluster-corrected). Controls n = 13, red; patients n = 15, blue.
Colorbars are t-values from 2.5 to 5. (For interpretation of the references to color in this
figure, the reader is referred to the online version of this chapter.)
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Controls showed a negative association between BOLD response
during the 2back task and subjective cognitive appraisal (as measured
by the verbalmemory score on theMASQ) in the left anterior insula/pu-
tamen, and right PMC/FrOP (p b 0.05 cluster-corrected; Fig. 4A, Table 4);
more cognitive complaint was associated with lower task-related acti-
vations in these regions.
Fibromyalgia patients also demonstrated a negative association
between subjective cognitive appraisal and BOLD response, but in a
separate set of brain regions, including the right supramarginal
gyrus/primary somatosensory cortex (SMG/S1) and posterior insula,
right IPL, left inferior temporal cortex/fusiform gyrus, and bilateral
occipital cortex (p b 0.05 cluster-corrected; Fig. 4B, Table 4). Patients
displayed significantly less negative correlation between subjective
cognitive appraisal and fMRI activity during working memory task
compared to healthy controls in the left putamen/anterior insula
(Fig. 4C, Table 4).
4. Discussion
The experience of cognitive dysfunction contributes prominently to
the symptoms that comprise the current concept of fibromyalgia. This
study evaluated subjective cognitive appraisal, objective taskTable 2
BOLD response during the N-back task (2 N 0back contrast).
Region Peak t-value Peak MNI
Controls (n = 13):
SMA (mid), PMC (L), DLPFC (R) 8.4 0, 16, 54
IPL (L), IPL (R) SMG (R) 8.4 −36,−5
DLPFC (R), ACC (mid) 7.6 44, 36, 32
VLPFC/FrOP (L), DLPFC (L) 7.1 −42, 54,
Insula (L) 6.4 −30, 22,
Patients (n = 15):
IPL (L), IPL (R) 7.4 44,−46,
DLPFC (R), SMA (mid), ACC (R) 7.2 28, 14, 54
Insula (L), VLPFC (L), DLPFC (L) 4.9 −30, 22,
Cerebellum 4.9 −36,−5
Controls N patients:
No significant clusters
Patients N controls:
No significant clusters
The threshold for these analyseswas set at a voxel-wise p b 0.01. Significant clusters corrected f
in these analyses were n = 13 controls and n = 15 patients.
SMA, supplemental motor area; PMC, premotor cortex; DLPFC, dorsolateral prefrontal cortex; I
tex; FrOP, frontal operculum; ACC, anterior cingulate cortex; mid, midline; L, left hemisphere;performance, and brain activity during task performance. These mea-
surements describe a clinical picture of “fibrofog” in which subjective
impairment is clinically considerable, yet distinguishable froma difficult
workingmemory task performance in which objective impairment was
minimal and no differences in BOLD activity were observed between
groups during task performance. However, a dissociation between
task accuracy and task-related BOLD responsewas observed in fibromy-
algia patients but not in controls. Further, increased subjective cognitive
appraisal was accompanied by a unique pattern of brain activation
during task performance. Simply put, fibromyalgia patients appear to
have a “disconnect” between the subjective experience of cognitive
problems and the objective reality of cognitive performance. The
amount of disconnect also appears to be related to the severity of
clinical symptoms.
These results are consistent with Čeko et al. (Čeko et al., 2015), in
that fibromyalgia patients performed similar to controls on the 2back
task. Our version of 2back appears to be more difficult than that used
by Seo et al., leading tomuch lower scores in both groups.We observed
a 15% difference in performance that did not reach significance. Expect-
ed brain activations associatedwith the 2backwere equivalent between
the groups after subtracting the easier condition (0back). Therefore,
“fibrofog” does not appear to be an inability to properly activate
task-related brain networks.
While group differences in the objective 2back task performance and
related BOLD response were not demonstrated, the groups differed
dramatically in the perception of their cognitive function (cognitive
appraisal). MASQ scores demonstrate that fibromyalgia patients have
a ~ 8.7 point (27.2%) increase in perceived dyscognition in each cogni-
tive domain tested. These differences appear to be clinically meaningful
(Williams and Arnold, 2011). This suggests that there is an important
discordance between subjective dyscognition and objective cognitive
performance. This discordance is all the more striking when subjective
cognitive appraisal is correlated with objective performance. Subjective
cognitive appraisal is predictive of 2back task accuracy in healthy volun-
teers (Pearson correlation r =−0.66, p = 0.02) but not predictive in
fibromyalgia patients (Pearson correlation r = 0.35, p = 0.27). This
discordance also appears to have a neurobiological correlate. Activity
in the right PMC/DLPFC, right anterior insula, and bilateral putamen
correlated with task accuracy in healthy volunteers; task accuracy
could not be attributed to any discrete brain activation in fibromyalgia
patients.
The lack of relationship between subjective experience and objective
performance is a key observation for understanding “fibrofog”. Similar
discordances are observed in many other symptomatic aspects of fibro-
myalgia in which perceived deficits are reported to be much greatercoordinate Cluster volume (voxels) Cluster p-value
5660 b0.001
6, 40 7316 b0.001
2459 b0.001
8 697 b0.022
4 622 b0.029
40 7196 b0.001
8354 b0.001
−8 565 0.036
4,−34 650 0.026
ormultiple comparisons at p b 0.05 using random field theory (RFT) are reported. Included
PL, inferior parietal lobule; SMG, supramarginal gyrus; VLPFC, ventrolateral prefrontal cor-
R, right hemisphere.
Fig. 3. Relationship between BOLD response and task performance. A) In controls, BOLD response during 2back was significantly positively correlated with 2back task accuracy in right
anterior insula (Freeman et al., 2011), bilateral putamen (Put), left caudate (Caud), and right premotor cortex/dorsolateral prefrontal cortex (PMC/DLPFC); p b 0.05 cluster-corrected.
There were no significant clusters in fibromyalgia patients. B) The positive correlation between BOLD response and task performance was significantly stronger in controls vs. patients
in the right anterior insula (Freeman et al., 2011); p b 0.05 cluster-corrected. Displayed on MNI standard brain. Scatter plots are showing mean BOLD signal (a.u.) in respective cluster
plotted against task accuracy (%). Controls n = 12, black circles; patients n = 15, red circles; L, left hemisphere. Colorbars are t-values from 2.5 to 5. (For interpretation of the
references to color in this figure, the reader is referred to the online version of this chapter.)
178 B. Walitt et al. / NeuroImage: Clinical 11 (2016) 173–180than those found on functional testing (Hidding et al., 1994). In this
way, the dyscognition of fibromyalgia appears similar to the “brain
fog” described in Gulf War Illness and other war-related illnesses,
(Binder et al., 1999; Hyams et al., 1996; Wallin et al., 2009) chronic
fatigue syndrome, (Capuron et al., 2006; Ocon, 2013) post-Lyme disease
syndrome, (Hassett et al., 2009) postural orthostatic tachycardia
syndrome, (Freeman et al., 2011) the “chemobrain” in cancer survivors,
(Tannock et al., 2004; Wang et al., 2015) the “brain fag” historically
described in neurasthenia, (Ross, 2004) and (perhaps) the ethnographic
illness “brain fag” documented in male African teenagers (Ola et al.,
2009). These disorders are characterized by distressing subjective
cognitive impairment without clinically obvious cognitive deficits.
This discordance is in contradistinction to neuropsychiatric
dementias with demonstrable pathology such as Alzheimer's disease,
Parkinson's disease, Wernicke's encephalopathy, Korsakoff Syndrome,
and vascular dementia, where the cognitive impairment is clinically
obvious. In these disorders, cognitive impairment is measured easily
using objective tests and ratings from relatives (McGlone et al., 1990).
In fact, a common clinical scenario in neuropsychiatric dementia is the
reverse of what is seen in fibromyalgia: clearly discernible cognitiveTable 3
Positive association between NBack-related BOLD response and task accuracy during the 2back
Region Peak t-value Peak MN
Controls (n = 12):
aINS (R), FrOP (R), Putamen (R) 4.4 32, 22, 8
Putamen (L), Caudate (L) 4.2 −24, 6, 6
PMC (R), DLPFC (R) 3.5 32,−2, 3
Patients (n = 15):
No significant clusters
Controls N patients:
aINS (R) 3.7 32, 22, 8
Patients N controls:
No significant clusters
The threshold for these analyseswas set at a voxel-wise p b 0.01. Significant clusters corrected f
in these analyses were n = 12 controls (performance data missing for one subject) and n = 1
aINS, anterior insula; FrOP, frontal operculum; PMC, premotor cortex; DLPFC, dorsolateral prefdeficits accompanied byminimization, confabulation, or outright denial
of these cognitive deficits by the afflicted (Weinstein et al., 1994).
Unlike fibromyalgia, these progressive dementias are associated
also with obvious physical disability and early mortality (Wolfe et al.,
2013). The dyscognition of fibromyalgia appears to be more a
problem of subjective cognitive appraisal – the privileged homeostatic
sensation that accompanies cognitive tasks – than of actual cognitive
performance.
Differences in cognitive appraisal, however, do appear to be associat-
ed with BOLD response during a cognitive task. Lower subjective
dyscognition in controls was associated with decreased activation of
the left putamen, left anterior insula, and right PMC/FrOP. Amorewide-
spread pattern was observed in fibromyalgia, with patients with the
highest levels of dyscognition demonstrating decreased activity in the
right SMG/S1 and posterior insula, right fusiform gyrus, right IPL, left in-
ferior temporal cortex, and bilateral fusiform gyrus and occipital cortex.
Negative correlations between cognitive appraisal and activation were
found in the left putamen/anterior insula of controls but not in fibromy-
algia patients. It is possible that these differences in task-related activa-
tions may contribute to the experience of “fibrofog”.task.
I coordinate Cluster volume (voxels) Cluster p-value
1447 0.004
584 0.047
2 629 0.040
648 0.038
ormultiple comparisons at p b 0.05 using random field theory (RFT) are reported. Included
5 patients.
rontal cortex; L, left hemisphere; R, right hemisphere.
Fig. 4. Relationship between BOLD response and perceived cognitive difficulty. A) In controls, BOLD response during 2back was significantly negatively correlated with the MASQ verbal
score in the left anterior insula /putamen (aINS/Put), and right premotor cortex/frontal operculum(PMC/FrOP); p b 0.05 cluster-corrected. B) In patients, BOLD response during 2backwas
significantly negatively correlatedwith theMASQverbal score in the right supramarginal gyrus/primary somatosensory cortex/posterior insula (SMG/S1/pINS0; p b 0.05 cluster-corrected.
C) The negative correlation between BOLD response and MASQ verbal score was significantly stronger in patients vs. controls in the left anterior insula/putamen (aINS/Put); p b 0.05
cluster-corrected. Displayed on MNI standard brain. Scatter plots are showing mean BOLD signal (a.u.) in respective cluster plotted against MASQ verbal memory score. Controls n =
12, black circles; patients n = 15, red circles; L, left hemisphere. Colorbars are t-values from 2.5 to 5. (For interpretation of the references to color in this figure, the reader is referred
to the online version of this chapter.)
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sents the entire experience of the task, action and subjective experience,
rather than being only a surrogate of ability. Fibromyalgia patients dem-
onstrate equivalent performance and BOLD response in the task-related
network when compared to matched controls, but also demonstrate
differing patterns of activity outside of the task network that correlate
with cognitive appraisal. These patterns may be interpreted in a variety
of ways. Task performance may lead to secondary, reflexive activations
or deactivations that provide a sense of cognitive appraisal. Alternatively,
these differences may not be related to task performance but rather
reflect differences in perception. It may be that patients with increased
cognitive complaints were more sensitive to the scanning environment
or more concerned about their ability to adequately perform, each with
their own neurobiological correlates. Our data cannot differentiate
between these possibilities, but do suggest that approaches that focus
solely on task performance and its associated activation patterns may
not provide sufficient answers to the nature of dyscognition in
fibromyalgia. Future approaches will need to compare the similarities
and differences of subjective and objective performance and their
neurobiologic correlates in tasks with a range of difficulties.Table 4
Negative association between NBack-related BOLD response during the 2back task and perceiv
Region Peak t-value Peak MN
Controls (n = 12):
Putamen (L), aINS (L) 4.8 −22, 8,
PMC (R), FrOP (R) 3.8 34,−2,
Patients (n = 15):
SMG/S1/pINS (R) 5.1 66,−30
Occipital/IPL (R), 5.2 48,−80
Inferior temporal (L), Fusiform (L) 4.5 −42,−
Fusiform (R) 4.4 30,−34
Occipital (L) 4.3 −36,−
Controls N patients:
No significant clusters
Patients N controls:
Putamen (L), aINS (L) −22, 6,
The threshold for these analyses was set at a voxel-wise p b 0.01. Significant clusters corrected
aINS, anterior insula; PMC, premotor cortex; FrOP, frontal operculum; SMG, supramarginal gyru
left hemisphere; R, right hemisphere.4.1. Limitations
This study has several limitations. The findings are from a compara-
tive cohort study with a relatively small sample size. A true but small
difference in performance might be demonstrated in a larger sample.
Overall subjective dyscognition was measured but not task-related
subjective dyscognition. Performance accuracy was measured only in
the scanning environment.
It is possible that the lack of difference in objective cognitive function
reported here is due to specifics in the study design, such as the use of
the N-back task. It is possible that other task designs may have found
objective differences in performance. However, N-back testing
represents a difficult cognitive task that requires attention, recall,
quick reactions, and persistence; all aspects of tasks described as
problematic by persons with fibromyalgia. N-back testing is sensitive
to cognitive impairment, as demonstrated in both Parkinson's disease
(Miller et al., 2009) and schizophrenia (Perlstein et al., 2001). We assert
that if “fibrofog” is associated with a gross deficit in working memory,
the N-back paradigm used in this study would have captured it. While
a single negative finding cannot conclusively demonstrate that there ised cognitive difficulty (MASQ verbal memory score).
I coordinate Cluster volume (voxels) Cluster p-value
14 579 0.044
30 709 0.028
, 30 7928 b0.001
, 8 1014 0.011
40,−6 1788 0.001
,−16 1193 0.006
74, 16 1299 0.005
14 611 0.040
for multiple comparisons at p b 0.05 using random field theory (RFT) are reported.
s; S1, primary somatosensory cortex; pINS, posterior insula; IPL, inferior parietal lobule; L,
180 B. Walitt et al. / NeuroImage: Clinical 11 (2016) 173–180no objective cognitive deficit in fibromyalgia, these results suggest that
any such deficit would be clinically insignificant.
It is also possible that the poor association between subjective symp-
tom reporting and objective cognitive performance is related to the in-
fluence of psychiatric variables, such as anxiety and depression.
However, psychological issues are such an essential part of the clinical
phenomenon of fibromyalgia that they cannot bemeaningfully separat-
ed. In the National Health Interview Survey, 62.7% of persons meeting
fibromyalgia criteria self-report a diagnosis of depression and 64.8%
report being “often anxious” (Walitt et al., 2015). In recognition that
fibromyalgia cannot be readily disassociated from psychiatric comor-
bidity, feeling depressed was added to the ACR diagnostic definition in
2011 (Wolfe et al., 2011).
5. Conclusion
In summary, these results suggest that “fibrofog” is better character-
ized by subjective rather than objective cognitive impairment. This
difference in cognitive appraisal appears to have neurologic correlates.
We opine that these differences reflect both the sensory and behavioral
aspects of task performance rather than a singular deficit in cognitive
ability in fibromyalgia patients.
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